标题
The impact of mitochondria on cancer treatment resistance
作者
关键词
-
出版物
CELLULAR ONCOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-07-10
DOI
10.1007/s13402-021-00623-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- ROS in cancer therapy: the bright side of the moon
- (2020) Bruno Perillo et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Small molecular Nrf2 inhibitors as chemosensitizers for cancer therapy
- (2020) Hongzhi Lin et al. Future Medicinal Chemistry
- Mitochondrial TCA cycle metabolites control physiology and disease
- (2020) Inmaculada Martínez-Reyes et al. Nature Communications
- Re-epithelialization and immune cell behaviour in an ex vivo human skin model
- (2020) Ana Rakita et al. Scientific Reports
- IDH mutation in glioma: molecular mechanisms and potential therapeutic targets
- (2020) Sue Han et al. BRITISH JOURNAL OF CANCER
- Role of Mitochondria in Cancer Stem Cell Resistance
- (2020) José Manuel García-Heredia et al. Cells
- Nestin Expression Affects Resistance to Chemotherapy and Clinical Outcome in Small Cell Lung Cancer
- (2020) Kazuki Sone et al. Frontiers in Oncology
- Cancer metabolism and mitochondria: Finding novel mechanisms to fight tumours
- (2020) Sonia Missiroli et al. EBioMedicine
- The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression
- (2019) Peter Vaupel et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Regulation of succinate dehydrogenase and role of succinate in cancer
- (2019) Elisa Dalla Pozza et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Nrf2 in cancers: A double‐edged sword
- (2019) Shijia Wu et al. Cancer Medicine
- Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway
- (2019) Yunjiang Zhou et al. Redox Biology
- Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
- (2019) Danielle Golub et al. Frontiers in Oncology
- Mitochondrial Involvement in Cisplatin Resistance
- (2019) Veronica Cocetta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Does the addition of chemotherapy to neoadjuvant radiotherapy impact survival in high‐risk extremity/trunk soft‐tissue sarcoma?
- (2019) Mudit Chowdhary et al. CANCER
- SIRT5 Promotes Cisplatin Resistance in Ovarian Cancer by Suppressing DNA Damage in a ROS-Dependent Manner via Regulation of the Nrf2/HO-1 Pathway
- (2019) Xiaodan Sun et al. Frontiers in Oncology
- Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress
- (2019) Richard Burt et al. BLOOD
- R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m 6 A/MYC/CEBPA Signaling
- (2018) Rui Su et al. CELL
- The role of IDH mutations in acute myeloid leukemia
- (2018) Guillermo Montalban-Bravo et al. Future Oncology
- Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
- (2018) Lukas Bunse et al. NATURE MEDICINE
- Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway
- (2018) Yukai Xiang et al. Oxidative Medicine and Cellular Longevity
- Mitochondrial transfer from mesenchymal stem cells to neural stem cells protects against the neurotoxic effects of cisplatin
- (2018) Nabila Boukelmoune et al. Acta Neuropathologica Communications
- Optimizing treatment in recurrent epithelial ovarian cancer
- (2017) Giacomo Corrado et al. Expert Review of Anticancer Therapy
- Metabolic shifts in residual breast cancer drive tumor recurrence
- (2017) Kristina M. Havas et al. JOURNAL OF CLINICAL INVESTIGATION
- Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo
- (2017) A Chaturvedi et al. LEUKEMIA
- SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers
- (2017) Corinna Altenberger et al. Molecular Cancer
- Cell plasticity in epithelial homeostasis and tumorigenesis
- (2017) Julia Varga et al. NATURE CELL BIOLOGY
- A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer
- (2017) E-J Choi et al. ONCOGENE
- Succinate: An initiator in tumorigenesis and progression
- (2017) Ting Zhao et al. Oncotarget
- Controversy about pharmacological modulation of Nrf2 for cancer therapy
- (2017) Lidija Milkovic et al. Redox Biology
- Power frequency magnetic field promotes a more malignant phenotype in neuroblastoma cells via redox-related mechanisms
- (2017) S. Falone et al. Scientific Reports
- Activation of apoptosis signalling pathways by reactive oxygen species
- (2016) Maureen Redza-Dutordoir et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cytokines in cancer drug resistance: Cues to new therapeutic strategies
- (2016) Valerie Sloane Jones et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy
- (2016) R. Moschoi et al. BLOOD
- Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters
- (2016) Xupeng Bai et al. DRUG METABOLISM REVIEWS
- Isocitrate dehydrogenase mutations in myeloid malignancies
- (2016) B C Medeiros et al. LEUKEMIA
- Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma
- (2016) A. T. Fathi et al. ONCOLOGIST
- Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS
- (2016) Megan V. Jackson et al. STEM CELLS
- Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
- (2016) Valentina Cappello et al. Scientific Reports
- Calcium and mitochondria in the regulation of cell death
- (2015) Sten Orrenius et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ascorbic acid reduces HMGB1 secretion in lipopolysaccharide-activated RAW 264.7 cells and improves survival rate in septic mice by activation of Nrf2/HO-1 signals
- (2015) So Ra Kim et al. BIOCHEMICAL PHARMACOLOGY
- Radioactive 125I seeds inhibit cell growth and epithelial-mesenchymal transition in human glioblastoma multiforme via a ROS-mediated signaling pathway
- (2015) Yunhong Tian et al. BMC CANCER
- Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells
- (2015) X Wang et al. CELL DEATH AND DIFFERENTIATION
- Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease
- (2015) Lauren E. Tebay et al. FREE RADICAL BIOLOGY AND MEDICINE
- Adaptive Mitochondrial Reprogramming and Resistance to PI3K Therapy
- (2015) Jagadish C. Ghosh et al. JNCI-Journal of the National Cancer Institute
- Germline Mutations in Predisposition Genes in Pediatric Cancer
- (2015) Jinghui Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
- (2015) Monica Cojoc et al. SEMINARS IN CANCER BIOLOGY
- Connecting Mitochondria, Metabolism, and Stem Cell Fate
- (2015) Anaïs Wanet et al. STEM CELLS AND DEVELOPMENT
- MitoCeption as a new tool to assess the effects of mesenchymal stem/stromal cell mitochondria on cancer cell metabolism and function
- (2015) Andrés Caicedo et al. Scientific Reports
- Adaptive Mitochondrial Reprogramming and Resistance to PI3K Therapy
- (2015) Jagadish C. Ghosh et al. JNCI-Journal of the National Cancer Institute
- Mitochondrial Transfer of Induced Pluripotent Stem Cell–Derived Mesenchymal Stem Cells to Airway Epithelial Cells Attenuates Cigarette Smoke–Induced Damage
- (2014) Xiang Li et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Mitochondrial metabolism directs stemness and differentiation in P19 embryonal carcinoma stem cells
- (2014) I Vega-Naredo et al. CELL DEATH AND DIFFERENTIATION
- p62/SQSTM1 is involved in cisplatin resistance in human ovarian cancer cells via the Keap1-Nrf2-ARE system
- (2014) MEIHUI XIA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Mesenchymal stem cells rescue injured endothelial cells in an in vitro ischemia–reperfusion model via tunneling nanotube like structure-mediated mitochondrial transfer
- (2014) Kaiming Liu et al. MICROVASCULAR RESEARCH
- Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy?
- (2014) Tongde Wu et al. MOLECULAR CARCINOGENESIS
- Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
- (2014) Andrea Viale et al. NATURE
- Diabetic Cardiomyopathy and Its Prevention by Nrf2: Current Status
- (2014) Jing Chen et al. Diabetes & Metabolism Journal
- R-2-Hydroxyglutarate as the Key Effector of IDH Mutations Promoting Oncogenesis
- (2013) Dan Ye et al. CANCER CELL
- Nrf2 is a potential therapeutic target in radioresistance in human cancer
- (2013) Suna Zhou et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- IDH mutations in tumorigenesis and their potential role as novel therapeutic targets
- (2013) Daniel Krell et al. Future Oncology
- Oncometabolites: linking altered metabolism with cancer
- (2013) Ming Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Which way does the citric acid cycle turn during hypoxia? The critical role of α-ketoglutarate dehydrogenase complex
- (2013) Christos Chinopoulos JOURNAL OF NEUROSCIENCE RESEARCH
- Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance
- (2013) Jennifer Pasquier et al. Journal of Translational Medicine
- Heterogeneity of tumor-induced gene expression changes in the human metabolic network
- (2013) Jie Hu et al. NATURE BIOTECHNOLOGY
- Initial activation of STIM1, the regulator of store-operated calcium entry
- (2013) Yubin Zhou et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Norcantharidin Induced DU145 Cell Apoptosis through ROS-Mediated Mitochondrial Dysfunction and Energy Depletion
- (2013) Bo Shen et al. PLoS One
- Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration
- (2013) K. M. Holmstrom et al. Biology Open
- The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer
- (2013) Emilia Kansanen et al. Redox Biology
- The three Rs along the TRAIL: Resistance, re-sensitization and reactive oxygen species (ROS)
- (2012) Gregory Mellier et al. FREE RADICAL RESEARCH
- Nrf2 Protein Up-regulates Antiapoptotic Protein Bcl-2 and Prevents Cellular Apoptosis
- (2012) Suryakant K. Niture et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity
- (2012) A Arlt et al. ONCOGENE
- Tunneling Nanotubes Provide a Unique Conduit for Intercellular Transfer of Cellular Contents in Human Malignant Pleural Mesothelioma
- (2012) Emil Lou et al. PLoS One
- A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer
- (2012) Youfeng Yang et al. Cancer Genetics
- Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?
- (2012) P. Borst Open Biology
- Fumarate hydratase inactivation in renal tumors: HIF1 alpha, NRF2, and "cryptic targets" of transcription factors
- (2012) Aikseng Ooi et al. Chinese Journal of Cancer
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
- (2011) Wei Xu et al. CANCER CELL
- Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling
- (2011) Julie Adam et al. CANCER CELL
- NRF2 Blockade Suppresses Colon Tumor Angiogenesis by Inhibiting Hypoxia-Induced Activation of HIF-1
- (2011) T.-H. Kim et al. CANCER RESEARCH
- Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs
- (2011) Xiuwen Tang et al. FREE RADICAL BIOLOGY AND MEDICINE
- The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation
- (2011) Ruoning Wang et al. IMMUNITY
- Inborn and acquired metabolic defects in cancer
- (2011) Christian Frezza et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
- (2011) M Fernanda Amary et al. JOURNAL OF PATHOLOGY
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
- (2011) Gina M. DeNicola et al. NATURE
- Metabolism unhinged: IDH mutations in cancer
- (2011) John R Prensner et al. NATURE MEDICINE
- Metabolic state of glioma stem cells and nontumorigenic cells
- (2011) E. Vlashi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Free radicals and antioxidants – quo vadis?
- (2011) Barry Halliwell TRENDS IN PHARMACOLOGICAL SCIENCES
- Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall
- (2010) William G. Kraybill et al. CANCER
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
- (2010) Patrick S. Ward et al. CANCER CELL
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- Structural studies on human 2-oxoglutarate dependent oxygenases
- (2010) Michael A McDonough et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Reactive oxygen species, cellular redox systems, and apoptosis
- (2010) Magdalena L. Circu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mild thermotolerance induced at 40°C protects HeLa cells against activation of death receptor-mediated apoptosis by hydrogen peroxide
- (2010) Pragathi Pallepati et al. FREE RADICAL BIOLOGY AND MEDICINE
- Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor Growth
- (2010) P. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Adaptive Therapy
- (2009) R. A. Gatenby et al. CANCER RESEARCH
- STIM1 Clusters and Activates CRAC Channels via Direct Binding of a Cytosolic Domain to Orai1
- (2009) Chan Young Park et al. CELL
- Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?
- (2009) Matthias Sieber et al. Cell Communication and Signaling
- STIM1 Is a Calcium Sensor Specialized for Digital Signaling
- (2009) Gary S. Bird et al. CURRENT BIOLOGY
- Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
- (2009) Yoo Ri Kim et al. JOURNAL OF PATHOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death
- (2009) D A Tennant et al. ONCOGENE
- Cancer Stem Cells in Solid Tumors: An Overview
- (2009) Catherine Adell O'Brien et al. SEMINARS IN RADIATION ONCOLOGY
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
- (2008) X.-J. Wang et al. CARCINOGENESIS
- Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer
- (2008) Tatsuhiro Shibata et al. GASTROENTEROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started